Andi Muçaj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andi Muçaj has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Federica Principi
Institute of Biochemistry, University of Ancona, Ancona, Italy
2 shared publicationsFrancesca Lacalaprice
Lancisi Heart Institute, Via Conca, 71 Torrette di Ancona, Italy
2 shared publicationsGian Paolo Littarru
Institute of Biochemistry, University of Ancona, Ancona, Italy
2 shared publications- Luca Tiano
Department of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy
2 shared publications Maridia Solenghi
Lancisi Heart Institute, Via Conca, 71 Torrette di Ancona, Italy
2 shared publications- Romualdo Belardinelli
Lancisi Heart Institute, Department of Cardiology and Cardiac Surgery, Ancona, Italy
2 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Excimer Laser Coronary Atherectomy (ELCA) Utilization in Complex PCI: A Position Paper of the Italian Society of Interventional Cardiology (SICI‐GISE)
Excimer laser coronary atherectomy (ELCA) has significantly influenced interventional cardiology, particularly in complex percutaneous coronary interventions (PCIs). This expert review by the Italian Society of Interventional Cardiology (SICI‐GISE) provides a comprehensive overview of ELCA's applications, mechanisms of action, and clinical significance. ELCA uses ultraviolet (UV) energy to modify atheromatous plaque while minimizing damage to surrounding tissue. Its photochemical, photothermal, and photokinetic mechanisms enable effective plaque removal and improved clinical outcomes. The review traces the evolution of ELCA technology, including advances in laser catheters and techniques for diverse clinical and anatomical scenarios. It also discusses ELCA's clinical applications for conditions such as in‐stent restenosis, underexpanded stents, thrombotic lesions, and calcified plaques. The review further examines the histopathological effects of ELCA on vascular tissues, emphasizing its precision and minimal collateral damage. Data from multiple studies demonstrate ELCA's effectiveness and safety in complex PCI, with high success rates and acceptable complication rates. The review emphasizes the importance of careful patient selection, appropriate laser settings, and adjunctive therapies to achieve optimal results. Overall, ELCA is a valuable tool for interventional cardiologists, offering a versatile and practical approach to managing challenging coronary lesions.
- 13 November 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Open AccessExcimer Laser Coronary Atherectomy (ELCA) Utilization in Complex PCI: A Position Paper of the Italian Society of Interventional Cardiology (SICI‐GISE)
Excimer laser coronary atherectomy (ELCA) has significantly influenced interventional cardiology, particularly in complex percutaneous coronary interventions (PCIs). This expert review by the Italian Society of Interventional Cardiology (SICI‐GISE) provides a comprehensive overview of ELCA's applications, mechanisms of action, and clinical significance. ELCA uses ultraviolet (UV) energy to modify atheromatous plaque while minimizing damage to surrounding tissue. Its photochemical, photothermal, and photokinetic mechanisms enable effective plaque removal and improved clinical outcomes. The review traces the evolution of ELCA technology, including advances in laser catheters and techniques for diverse clinical and anatomical scenarios. It also discusses ELCA's clinical applications for conditions such as in‐stent restenosis, underexpanded stents, thrombotic lesions, and calcified plaques. The review further examines the histopathological effects of ELCA on vascular tissues, emphasizing its precision and minimal collateral damage. Data from multiple studies demonstrate ELCA's effectiveness and safety in complex PCI, with high success rates and acceptable complication rates. The review emphasizes the importance of careful patient selection, appropriate laser settings, and adjunctive therapies to achieve optimal results. Overall, ELCA is a valuable tool for interventional cardiologists, offering a versatile and practical approach to managing challenging coronary lesions.
- 7 October 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 198 (Pt A) , 111172
FedStenoNet: tackling domain shift in x-ray coronary angiography through a personalized federated detection framework
- 7 October 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 198 (Pt A) , 111172
FedStenoNet: tackling domain shift in x-ray coronary angiography through a personalized federated detection framework
- 29 March 2012
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (3) , 757-761
Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn
- 29 March 2012
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (3) , 757-761
Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn
- Open Access
- 11 April 2006
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (22) , 2675-2681
Coenzyme Q10 and exercise training in chronic heart failure
Aims There is evidence that plasma coenzyme Q10 (CoQ10) levels decrease in patients with advanced chronic heart failure (CHF). However, it is not known whether oral CoQ10 supplementation may improve cardiocirculatory efficiency and endothelial function in patients with CHF.
- 11 April 2006
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (22) , 2675-2681
Open AccessCoenzyme Q10 and exercise training in chronic heart failure
Aims There is evidence that plasma coenzyme Q10 (CoQ10) levels decrease in patients with advanced chronic heart failure (CHF). However, it is not known whether oral CoQ10 supplementation may improve cardiocirculatory efficiency and endothelial function in patients with CHF.
- 1 January 2005
- Published by Wiley in BioFactors
- Vol. 25 (1-4) , 137-145
Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure
Background: There is evidence that plasma CoQ10 levels decrease in patients with advanced chronic heart failure (CHF).Objective: To investigate whether oral CoQ10 supplementation could improve cardiocirculatory efficiency in patients with CHF.Methods: We studied 21 patients in NYHA class II and III (18M, 3W, mean age 59 ±9 years) with stable CHF secondary to ischemic heart disease (ejection fraction 37 ± 7%), using a double‐blind, placebo‐controlled cross‐over design. Patients were assigned to oral CoQ10 (100 mg tid) and to placebo for 4 weeks, respectively.Results: CoQ10 supplementation resulted in a threefold increase in plasma CoQ10 level (P10 supplementation (+12.1 and 15.6%, respectively, P10 levels (r=−0.52, P10 as compared with placebo (+13%, 10.Conclusions: Oral CoQ10 improves LV contractility in CHF without any side effects. This improvement is associated with an enhanced functional capacity.
- 1 January 2005
- Published by Wiley in BioFactors
- Vol. 25 (1-4) , 137-145
Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure
Background: There is evidence that plasma CoQ10 levels decrease in patients with advanced chronic heart failure (CHF).Objective: To investigate whether oral CoQ10 supplementation could improve cardiocirculatory efficiency in patients with CHF.Methods: We studied 21 patients in NYHA class II and III (18M, 3W, mean age 59 ±9 years) with stable CHF secondary to ischemic heart disease (ejection fraction 37 ± 7%), using a double‐blind, placebo‐controlled cross‐over design. Patients were assigned to oral CoQ10 (100 mg tid) and to placebo for 4 weeks, respectively.Results: CoQ10 supplementation resulted in a threefold increase in plasma CoQ10 level (P10 supplementation (+12.1 and 15.6%, respectively, P10 levels (r=−0.52, P10 as compared with placebo (+13%, 10.Conclusions: Oral CoQ10 improves LV contractility in CHF without any side effects. This improvement is associated with an enhanced functional capacity.
- 1 April 2003
- Published by S. Karger AG in Urologia Internationalis
- Vol. 70 (3) , 227-231
Massive Spontaneous Perirenal Hematoma and Accelerated Hypertension in a Patient with Polyarteritis nodosa
A 43-year-old Albanian man is presented who underwent nephrectomy for a huge right spontaneous perirenal hematoma. The diagnosis of polyarteritis nodosa as the etiology of the hematoma has been made only by histological examination, because of the quick and unforeseeable onset of this complication and the nonspecificity of symptoms. We hypothesize a relationship between reactivation of polyarteritis nodosa and treatment with rifampicin and isoniazid.
- 1 April 2003
- Published by S. Karger AG in Urologia Internationalis
- Vol. 70 (3) , 227-231
Massive Spontaneous Perirenal Hematoma and Accelerated Hypertension in a Patient with Polyarteritis nodosa
A 43-year-old Albanian man is presented who underwent nephrectomy for a huge right spontaneous perirenal hematoma. The diagnosis of polyarteritis nodosa as the etiology of the hematoma has been made only by histological examination, because of the quick and unforeseeable onset of this complication and the nonspecificity of symptoms. We hypothesize a relationship between reactivation of polyarteritis nodosa and treatment with rifampicin and isoniazid.
- 1 March 2000
- Vol. 1 (3) , 216-20
Evaluation of ischemia-reperfusion damage during coronary angioplasty. Electrocardiographic assessment and biochemical modifications in blood from the coronary sinus.
Percutaneous transluminal coronary angioplasty (PTCA) constitutes a clinical model of reperfusion following a short period of ischemia connected to balloon inflation during the procedure. During the procedure some ischemic damage and oxidative injury related to free radical attack might occur. In the present study we investigated the extent of ischemic damage and some biochemical indexes of reperfusion damage in patients undergoing PTCA. Twenty-five patients who underwent PTCA because of angiographically detected occlusion of the coronary artery were enrolled. Balloon inflation lasted from 30 to 60 s. ECG changes were monitored throughout the procedure and blood samples were taken from the coronary artery and coronary sinus before balloon inflation, and again from coronary sinus at the peak of ischemia, 2 and 10 min after reperfusion. During PTCA procedure angina pectoris appeared in 62.7% of patients, whereas ST-segment elevation was present in 87% of patients, regressing completely after balloon deflation. Plasma malonyldialdehyde, an index of lipid peroxidation, did not change; coenzyme Q10 (in its oxidized and reduced forms), vitamin E and beta-carotene were also unchanged. Total antioxidant capacity and uric acid decreased upon reperfusion. Myocardial ischemia occurring during balloon inflation is brief and regresses completely after balloon deflation. Reperfusion following a short period of acute ischemia such as in PTCA does not constitute an oxidative event detectable through a common marker of lipid peroxidation nor does it alter the concentration of lipophilic antioxidants. It only lowers hydrosoluble antioxidants therefore representing a mild oxidative insult.
- 1 March 2000
- Vol. 1 (3) , 216-20
Evaluation of ischemia-reperfusion damage during coronary angioplasty. Electrocardiographic assessment and biochemical modifications in blood from the coronary sinus.
Percutaneous transluminal coronary angioplasty (PTCA) constitutes a clinical model of reperfusion following a short period of ischemia connected to balloon inflation during the procedure. During the procedure some ischemic damage and oxidative injury related to free radical attack might occur. In the present study we investigated the extent of ischemic damage and some biochemical indexes of reperfusion damage in patients undergoing PTCA. Twenty-five patients who underwent PTCA because of angiographically detected occlusion of the coronary artery were enrolled. Balloon inflation lasted from 30 to 60 s. ECG changes were monitored throughout the procedure and blood samples were taken from the coronary artery and coronary sinus before balloon inflation, and again from coronary sinus at the peak of ischemia, 2 and 10 min after reperfusion. During PTCA procedure angina pectoris appeared in 62.7% of patients, whereas ST-segment elevation was present in 87% of patients, regressing completely after balloon deflation. Plasma malonyldialdehyde, an index of lipid peroxidation, did not change; coenzyme Q10 (in its oxidized and reduced forms), vitamin E and beta-carotene were also unchanged. Total antioxidant capacity and uric acid decreased upon reperfusion. Myocardial ischemia occurring during balloon inflation is brief and regresses completely after balloon deflation. Reperfusion following a short period of acute ischemia such as in PTCA does not constitute an oxidative event detectable through a common marker of lipid peroxidation nor does it alter the concentration of lipophilic antioxidants. It only lowers hydrosoluble antioxidants therefore representing a mild oxidative insult.